Additionally, the serum biomarkers fibroblast growth factor 21 (FGF21) and glutamic-oxaloacetic transaminase 1 (GOT1) were significantly up-regulated in drug induced NAFLD. This evidence concerns the gene GOT1 and metabolic dysfunction-associated steatotic liver disease.